Hospital Clinico Universitario De Valladolid — Clinical Trial Site

112 Registered trials

41 Currently recruiting

Organisation

Hospital Clinico Universitario De Valladolid

Location

Valladolid, Spain

Identifier

ORG-100043716

Address

Avenida Ramon Y Cajal 3, 47003, Spain

Departments

#2323:servicio de neurología
#724002:Neurología
1213:Oncología Médica
3142: endocrinología y nutrición
7017: Oncología
Anaesthesiology
Cardiología
Cardiology
Cardiovascular surgery
Departamento de Neurología
Department of Neurology
Digestive
Digestive service
Digestive System
Endocrinología y Nutrición
Endocrinology and nutrition
Gastroenterology
Hematology Service
Hepatology
Infectious Diseases
Interventional Cardiology
Medica Oncology
Medical oncology
Microbiología e Inmunología
N/A
NA
Nephrology
Neurología
Neurology
Neurology Department
Oftalmología
Oncology
Oncology Service
Ophthalmology
Ophthalmology service
ORL
Orthopaedic Surgery and Traumatology
Orthopedic and Traumatology surgery
Pediatric oncology and hematology department
Preventive Medicine
Preventive medicine and public health service
Radiation Oncology
Servicio de digestivo
Servicio de Digestivo
Servicio de Hematologia; ext 86331
Servicio de Neurología
Servicio de Neurologia Unidad de Ictus
Servicio de Oncologia
Servicio de Oncología y Hematología Pediátricas
Servicio Medicina Intensiva
Stroke Unit
Urology

Clinical trials at this site (112)

Search interface

Ursodeoxycolic acid for the prevention of relapsing complications after gallstone acute pancreatitis, a double-blind multicenter randomized-… Pending

2024-518237-28-00 recurrence of acute biliary pancreatitis 6
EValuating the Effect of periopeRaTIve sodium-Glucose cOtransporter 2 inhibitors on cardiac surgery associated acute kidney injury: the VERT… Pending

2024-519997-37-00 Cardiac-surgery associated acute kidney injury 5
Prospective, randomized, multicentre study to compare the efficacy at 52 weeks (1 year) of biosimilar teriparatide and alendronate in the pr… Pending

2025-521301-40-00 Prevention of new morphometric vertebral fractures and/ 6
A clinical study to investigate the safety and tolerability of efimosfermin alfa injection in participants with known or suspected F2- or F3… Pending

2025-523674-16-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5
A pivotal clinical study to investigate the safety and efficacy of efimosfermin alfa injection in participants with biopsyconfirmed F2- or F… Pending

2025-523675-39-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5
Phase III randomized international open label clinical trial of treatment Intensification with docetaxel plus apalutamide in patients with m… Recruiting

2025-524408-30-01 Metastatic hormone-sensitive prostate cancer 5 2026-06-05
STAMPEDE2: A randomised controlled platform trial testing treatments in metastatic hormone sensitive prostate cancer Recruiting

2025-522145-21-00 Metastatic hormone sensitive prostate cancer 5 2026-04-13
VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA) Recruiting

2024-512436-29-00 CARDIOVASCULAR DISEASES 11 2026-03-27
Early treatment of irregular heartbeat (atrial fibrillation) to prevent a recurrent stroke Recruiting

2025-521260-35-00 acute ischemic stroke and atrial fibrillation (AF) 6 2025-11-07
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis Recruiting

2023-504358-36-00 multiple sclerosis 5 2024-10-17
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting

2023-508441-41-00 Bacteriemia producida por P. aeruginosa. 6 2024-07-08
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients Recruiting

2023-509220-17-00 Metastatic solid tumors 7 2026-04-10
Darovasertib before Surgery or Radiation Therapy to Treat Early-stage Eye Cancer (Uveal Melanoma) Recruiting

2025-522387-32-00 Uveal Melanoma 5 2026-04-10
EFFICACY OF FARICIMAB IN PATIENTS WITH SUBRETINAL HYPER-REFLECTIVE MATERIAL Recruiting

2025-522701-38-00 SUBRETINAL HYPERREFLECTIVE MATERIAL 6 2026-02-26
A trial to learn how safe Dato-DXd is and how well it works in people with NSCLC that has advanced after receiving osimertinib Recruiting

2024-511362-37-00 Non squamous non-small cell lung cancer (NSCLC) 5 2026-02-18
Patient-Centered Study of T-DXd in Metastatic HER2-Positive Breast Cancer with Real-Life Side Effect Management Recruiting

2025-521805-41-00 Patients with HER2-positive, locally advanced or metast 5 2026-02-18
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee ( ATTAIN-OA PAIN ) Recruiting

2025-522631-34-00 Osteoarthritis 5 2026-01-14
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy. Recruiting

2025-521640-38-00 Focal onset seizures or primary generalized tonic-cloni 5 2025-10-16
Effect of levothyroxine and hypocaloric diet for the treatment of obesity. Recruiting

2024-514377-22-00 Metabolic disease 5 2025-09-04
EORTC 2022-MG: Treatment with tebentafusp or observation for patients with melanoma of the eye after surgery or radiation (ATOM Trial) Recruiting

2023-510333-28-00 Uveal Melanoma 5 2025-08-20
SAKK 08/23: Addition of Darolutamide to first line treatment of mCRPC: a randomized open label phase II trial Recruiting

2024-512132-29-00 Metastatic castration-resistant prostate cancer 4 2025-08-06
Safety and Efficacy of Intravenous Thrombolysis in Patients with Ischemic Stroke on Treatment with Direct Oral Anticoagulants: DO-IT – The D… Recruiting

2024-515561-34-01 Acute ischemic stroke with recent ingestion of direct o 6 2025-08-04
Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION) Recruiting

2024-519521-37-01 Acute ischemic stroke 10 2025-07-30
Recombinant coagulation Factor VIIa administered at the earliest time for the treatment of stroke caused by bleeding in the brain - FASTEST… Recruiting

2024-517383-28-00 Acute haemorrhagic stroke 5 2025-07-21